Impact of imaging parameters of <sup>18</sup>F‐fluorodeoxyglucose positron emission tomography/computed tomography on treatment response to pembrolizumab in patients with metastatic urothelial carcinoma
Impact of imaging parameters of 18F‐fluorodeoxyglucose positron emission tomography/computed tomography on treatment response to pembrolizumab in patients with metastatic urothelial carcinoma
Hajime Tanaka, Yuma Waseda, Soichiro Yoshida, Junichi Tsuchiya et al.
Journal
International Journal of Urology
Topics
Bladder and Urothelial Cancer Treatments
article
Impact of imaging parameters of 18F‐fluorodeoxyglucose positron emission tomography/computed tomography on treatment response to pembrolizumab in patients with metastatic urothelial carcinoma